'lizbeth, I believe they were treated with Herceptin - the abstract states:
Quote:
we aimed to assess the outcome of early breast cancer patients per subtype based on HER2 and HR status in daily practice treated in a time period of routine use of anti-HER2 treatment.
|
(emphasis added).
The time frame covered was 2005- 2007.
Hopeful